AGC Biologics, a global biopharmaceutical CDMO, expanded capacity with the addition of three new Grade B cell therapy suites to its Longmont, CO facility.    The new addition at Longmont provides two new Process Suites and one new Flex suite, bringing expanded capabilities to its Colorado site. With more than 30,000 square feet of added space, the new segregated, multiproduct suites feature state-of-art modular clean room design, flexible capacity configuration, and the latest cell therapy equ...